NRXP Latest Headlines

Thomas Shrader Reiterates Buy on NRXP, Maintains $25 Price Target on NRX-100/101 FDA and RWE-Driven Upside

at www.tipranks.com (Tue, 23-Jun 6:15 AM)

NRx Pharmaceuticals Schedules Q1 2026 Results and Highlights Progress on Neurological Drug Pipeline

Market Chameleon (Thu, 14-May 11:45 AM)

Presidential Executive Order Accelerates Pathways for NRx Pharmaceuticals’ Psychedelic Treatments

Market Chameleon (Mon, 20-Apr 10:33 AM)

NRx Pharmaceuticals Cuts Costs and Eyes Regulatory Milestones as Debt-Free Path Fuels Clinic Expansion

Market Chameleon (Wed, 25-Mar 11:54 AM)